As for NSCLC patients, limited evidence is found, just two related existing studies: one literature shows that CCT6A is related to worse survival of NSCLC patients, but that previous finding is only supported by gene expression analysis in The Cancer Genome Atlas (TCGA) [19]; and another study suggests that CCT6A expression levels positively correlate with metastasis in patients with high TGF-β expression, while their findings are based on data collected from MSKCC NSCLC data sets [16]. Here, TGFB1 is linked to non-small cell lung carcinoma.